Biogen Inc. (NASDAQ: BIIB) is a large market cap stock with a market cap of 52980.37. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 14.87, a forward P/E of 12.03 and EPS of 16.28. At a stock price of 242.03 (-1.24%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 31.30%, more recently this last year it has grown by 24.00%. The next year growth is going to be about 6.66% and more long-term 7.80% after five years. EPS growth quarter over quarter is 26.80%. Sales growth for the past five years have been 17.90% and sales growth quarter over quarter is 6.70%.
For performance, Biogen Inc. the past week has seen a gain of 7.76%. For the last month performance for Biogen Inc. is -16.61%. While the last quarter is -8.88% and half year, -17.85%. Finally for the year, performance is -40.18%.
The 52-week high for Biogen Inc., is at -41.29%, and for the 52-week low it comes to a value of 8.52%. The 20-day simple moving average is -7.38% and -11.30% for the 200-day simple moving average.
Volatility for the week is at 2.28%, and for the month it is 2.40%. Biogen Inc., has a target price of 333.47.
In terms of debt, long term debt/equity is 0.63, and for total debt/equity Biogen Inc. has 0.63. The gross margin is 88.70%, while operating margin is 47.10%, the profit margin is 33.80%. The current ratio is 2.6 and the quick ratio is 2.2.
Insider ownership is at 0.10%, with instituitional ownership at 88.50%. Biogen Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 218.9. The shares float is 218.43, with the float short at 1.01%, with short ratio coming to 1.19.
In terms of returns, the return on assets see Biogen Inc., get 19.00%, with its returns on investment at 23.50%. Return on equity is 34.50%. So will the investors see the target price of 333.47, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.